Rhythm (United states)
company in Boston, United States
RYTM Nasdaq
ISIN US76243J1051 SEC CIK 1649904 LEI 529900JPNWXQ8DPLA551
Follow Rhythm (United states)
Weekly email: filings, results
Revenue, last quarter
$92.1M
+79.6% vs same quarter last year
Net income
−$41.4M
+21.8% vs same quarter last year
EPS, diluted
−$0.61
+25.6% vs same quarter last year
Operating cash flow
−$3.1M
+88.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $189.8M | −$196.5K |
| FY24 | $130.1M | −$260.6K |
| FY23 | $77.4M | −$184.7K |
| FY22 | $23.6M | −$181.1K |
| FY21 | $3.2M | −$69.6K |
| FY20 | $0 | −$134M |
| FY19 | $0 | −$140.7M |
| FY18 | $0 | −$74.1M |
| FY17 | $0 | −$33.7M |
| FY16 | $0 | −$25.9M |
| FY15 | - | −$11.1M |
| FY14 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 89.7% | −101.2% | −0.1% |
| FY24 | 89.7% | −204% | −0.2% |
| FY23 | 88% | −238.1% | −0.2% |
| FY22 | 91% | −757.9% | −0.8% |
| FY21 | 81% | −5391.9% | −2.2% |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$116.6M |
| FY24 | −$113.9M |
| FY23 | −$136.2M |
| FY22 | −$173.7M |
| FY21 | −$146.4M |
| FY20 | −$122.2M |
| FY19 | −$126.1M |
| FY18 | −$62.8M |
| FY17 | −$29.6M |
| FY16 | −$24.3M |
| FY15 | −$6.8M |
| FY14 | - |
- Rhythm (United states)
- Healthcare median
Show the numbers
| Year | Rhythm (United states) | Healthcare median |
|---|---|---|
| FY25 | −0.1% | −30.6% |
| FY24 | −0.2% | −47% |
| FY23 | −0.2% | −58% |
| FY22 | −0.8% | −80.4% |
| FY21 | −2.2% | −71.8% |
| FY20 | - | −62.2% |
| FY19 | - | −46.2% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −37.8% |
| FY14 | - | −35.5% |